WuXi XDC Cayman (FRA:L74) Price-to-Owner-Earnings : (As of May. 25, 2024)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Price-to-Owner-Earnings?

As of today (2024-05-25), WuXi XDC Cayman's share price is €1.67. WuXi XDC Cayman does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for WuXi XDC Cayman's Price-to-Owner-Earnings or its related term are showing as below:

FRA:L74's Price-to-Owner-Earnings is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 24.65
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-25), WuXi XDC Cayman's share price is €1.67. WuXi XDC Cayman's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.02. Therefore, WuXi XDC Cayman's PE Ratio for today is 83.50.

As of today (2024-05-25), WuXi XDC Cayman's share price is €1.67. WuXi XDC Cayman's EPS without NRI for the trailing twelve months (TTM) ended in was €0.02. Therefore, WuXi XDC Cayman's PE Ratio without NRI for today is 92.78.

During the past 4 years, WuXi XDC Cayman's highest PE Ratio without NRI was 103.09. The lowest was 44.81. And the median was 63.27.

WuXi XDC Cayman Price-to-Owner-Earnings Historical Data

The historical data trend for WuXi XDC Cayman's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Price-to-Owner-Earnings Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Owner-Earnings

WuXi XDC Cayman Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Price-to-Owner-Earnings	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of WuXi XDC Cayman's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi XDC Cayman's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Price-to-Owner-Earnings falls into.

WuXi XDC Cayman Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

WuXi XDC Cayman's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	1.67	/	0.00
	=

WuXi XDC Cayman (FRA:L74) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

WuXi XDC Cayman Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman (FRA:L74) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (FRA:L74) » Definitions » Price-to-Owner-Earnings

Comparable Companies

Traded in Other Exchanges

02268:Hong Kong

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (FRA:L74) Headlines

No Headlines